Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025)
Agios Pharmaceuticals' (AGIO) quarterly Tax Provisions came in at -$1.0 million in Q4 2025, up 88.55% YoY from -$538839.4 in Q4 2024, and up 88.55% on a QoQ basis from -$8.9 million in Q4 2024.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 5 years of Tax Provisions data on file, last reported at -$1.0 million in Q4 2025.
- Quarterly Tax Provisions rose 88.55% year-over-year to -$1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.2 million (down 2.3% YoY) and the FY2025 annual result came in at -$1.0 million, down 102.3% from the prior year.
- Tax Provisions improved to -$1.0 million in Q4 2025, from -$8.9 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $53.1 million in Q3 2024 to a low of -$8.9 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | -8.88 Mn |
| Sep 30, 2024 | 53.12 Mn |
| Dec 31, 2014 | 22,000.00 |
| Sep 30, 2014 | -448,000.00 |
| Dec 31, 2013 | -3.67 Mn |
| Sep 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 99,000.00 |
| Mar 31, 2013 | 190,000.00 |
| Dec 31, 2012 | -3.09 Mn |
| Sep 30, 2012 | -1.92 Mn |
| Jun 30, 2012 | -2.37 Mn |